Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Jackson

Showing results (191-200 of 251) with videos related to

Pageof 26
Sort By:
Mutation Research|March 26, 2003
Changes in the human mitochondrial genome after treatment of malignant diseaseTheresa M Wardell, Elaine Ferguson, Patrick F Chinnery, et al.
Transplantation|July 23, 2009
Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during primingXiao-Nong Wang, Muzlifah A Haniffa, Udo Holtick, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factorsXiao-Nong Wang, Matthew Collin, Lisbet Sviland, et al.
JAMA|June 22, 2002
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trialPatrick W J C Serruys, Pim de Feyter, Carlos Macaya, et al.
Bulletin of the World Health Organization|April 4, 2006
Counting the dead and what they died ofLars Age Johansson, Gérard Pavillon, Robert Anderson, et al.
Blood Cancer Journal|October 15, 2020
An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamicsPhuc H Hoang, Alex J Cornish, Amy L Sherborne, et al.
British Journal of Haematology|April 27, 2012
Diagnosis and management of acute graft-versus-host diseaseFiona L Dignan, Andrew Clark, Persis Amrolia, et al.
British Journal of Haematology|April 23, 2010
A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myelomaGuy Pratt, James A L Fenton, David Allsup, et al.
Oncology and Therapy|June 4, 2023
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple MyelomaStephen Palmer, Yi Lin, Thomas G Martin, et al.
Leukemia|October 16, 2019
The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trialCharlotte Pawlyn, David Cairns, Martin Kaiser, et al.
Pageof 26

Showing results (191-200 of 251) with videos related to

Sort By:
Pageof 26
Mutation Research|March 26, 2003
Changes in the human mitochondrial genome after treatment of malignant diseaseTheresa M Wardell, Elaine Ferguson, Patrick F Chinnery, et al.
Transplantation|July 23, 2009
Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during primingXiao-Nong Wang, Muzlifah A Haniffa, Udo Holtick, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factorsXiao-Nong Wang, Matthew Collin, Lisbet Sviland, et al.
JAMA|June 22, 2002
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trialPatrick W J C Serruys, Pim de Feyter, Carlos Macaya, et al.
Bulletin of the World Health Organization|April 4, 2006
Counting the dead and what they died ofLars Age Johansson, Gérard Pavillon, Robert Anderson, et al.
Blood Cancer Journal|October 15, 2020
An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamicsPhuc H Hoang, Alex J Cornish, Amy L Sherborne, et al.
British Journal of Haematology|April 27, 2012
Diagnosis and management of acute graft-versus-host diseaseFiona L Dignan, Andrew Clark, Persis Amrolia, et al.
British Journal of Haematology|April 23, 2010
A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myelomaGuy Pratt, James A L Fenton, David Allsup, et al.
Oncology and Therapy|June 4, 2023
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple MyelomaStephen Palmer, Yi Lin, Thomas G Martin, et al.
Leukemia|October 16, 2019
The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trialCharlotte Pawlyn, David Cairns, Martin Kaiser, et al.
Pageof 26